Dr. Robin Winter-Sperry started working in the industry in the area of Dermatology.  She has had a long and distinguished career including Sanofi/Genzyme Global Medical Affairs, Strategy & Tactics in the area of Multiple Sclerosis and President and CEO of Scientific Advantage, LLC. She created Novartis’ Medical Science Liaison (MSL)  department of Scientific Operations and Sanofi-Synthelabo’s Medical Therapeutic Liaison division. She has been involved in over 28 product launches.  She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading Medical Affairs and Medical Liaison teams.